Peptide Center / BPC-157
Not FDA-approvedBPC-157: evidence, status & safety
BPC-157 is a synthetic peptide promoted online for tendon, ligament, muscle, gastrointestinal and postoperative healing. It is not an FDA-approved human drug.
What patients should know first
| Commonly discussed for | Faster injury recovery, reduced inflammation and “gut healing.” |
| What efficacy data show | No robust randomized human clinical trials establish efficacy for sports injury, postoperative recovery, chronic pain or gastrointestinal healing. Most claims derive from animal studies, mechanisms and testimonials. |
| Approval boundary | Research findings do not establish a clinically validated dose, route, product standard or benefit in humans. |
| Safety context | FDA identifies limited safety information, potential immunogenicity and complexity involving peptide-related impurities and active-ingredient characterization. Unknown-source injection adds sterility and potency risk. |
Do not confuse a molecule with a verified medication
The name of an active ingredient does not verify the product in a vial. FDA approval, when it exists, applies to a specific product and indication. A compounded version is not FDA-approved, and a research-labeled product is not approved for human use.
Clinical supervision should include diagnosis, contraindication and interaction review, realistic outcome discussion, a valid prescription, traceable sourcing and follow-up. It cannot make an anonymous or counterfeit product safe.
Questions to ask
- Is there an FDA-approved product for my exact condition?
- What human outcome—not only biomarker—supports this use?
- What are the important contraindications and stopping rules?
- Which licensed pharmacy will dispense the prescription?
- How will response and adverse effects be monitored?
Verify the evidence
Know the status.
Verify the source.
This guide is educational and cannot determine whether BPC-157 is appropriate for you.
Move from information to the right next step.
Explore connected treatment guidance, meet the clinical team or begin a personalized consultation.
Patient education developed from primary regulatory, labeling and professional sources.
Chief Medical Officer – Texas · Aesthetic medicine, hormone optimization and peptide therapy.
